Document

Final Revised Vaccine Information Materials for 9-valent HPV (Human Papillomavirus) Vaccine

Under the National Childhood Vaccine Injury Act (NCVIA)(42 U.S.C. 300aa-26), CDC must develop vaccine information materials that all health care providers are required to give t...

Under the National Childhood Vaccine Injury Act (NCVIA)(42 U.S.C. 300aa-26), CDC must develop vaccine information materials that all health care providers are required to give to patients/parents prior to administration of specific vaccines. On October 22, 2015, CDC published a notice in the Federal Register (80 FR 64002) seeking public comments on proposed updated vaccine information materials for 9-valent HPV (Human Papillomavirus) Gardasil[supreg]-9 vaccine. Following review of comments submitted and consultation as required under the law, CDC has finalized the materials. Copies of the final vaccine information materials for 9-valent HPV Gardasil[supreg]-9 vaccine are available to download from http://www.cdc.gov/vaccines/hcp/vis/index.html or http:// www.regulations.gov (see Docket Number CDC-2015-0089).

Legal Citation

Federal Register Citation

Use this for formal legal and research references to the published document.

81 FR 23299

Web Citation

Suggested Web Citation

Use this when citing the archival web version of the document.

“Final Revised Vaccine Information Materials for 9-valent HPV (Human Papillomavirus) Vaccine,” thefederalregister.org (April 20, 2016), https://thefederalregister.org/documents/2016-09167/final-revised-vaccine-information-materials-for-9-valent-hpv-human-papillomavirus-vaccine.